Found: 6
Select item for more details and to access through your institution.
Thymidine kinase 1 appears to be a marker for the prognosis of hepatocellular carcinoma based on a large-scale, multicenter study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 15, p. 14271, doi. 10.1007/s00432-023-05089-z
- By:
- Publication type:
- Article
A propensity score matching study on survival benefits of radiotherapy in patients with inoperable hepatocellular carcinoma.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-34135-6
- By:
- Publication type:
- Article
PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching study.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.972503
- By:
- Publication type:
- Article
Effect of external beam radiation therapy versus transcatheter arterial chemoembolization for non-diffuse hepatocellular carcinoma (= 5 cm): a multicenter experience over a ten-year period.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1265959
- By:
- Publication type:
- Article
Construction and validation of a nomogram for HBV-related hepatocellular carcinoma: A large, multicenter study.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2023, v. 28, n. 4, p. 1, doi. 10.1016/j.aohep.2023.101109
- By:
- Publication type:
- Article
Construction of an interpretable model for predicting survival outcomes in patients with middle to advanced hepatocellular carcinoma (=5 cm) using lassocox regression.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1452201
- By:
- Publication type:
- Article